Achieve Life Sciences's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Achieve Life Sciences (NASDAQ:ACHV) is expected to report a Q4 earnings per share (EPS) of $-0.31 on March 28, 2024. Analysts and investors will be looking for an earnings beat and positive guidance for future growth. The company's past earnings performance shows a mix of beats and misses, with the share price reacting variably. Currently, shares are trading at $4.66, down 27.85% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.
March 27, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Achieve Life Sciences is anticipated to report a Q4 EPS of -$0.31, with investors hoping for an earnings beat and positive future guidance. The stock has seen a 27.85% decline over the past year, indicating bearish sentiment.
The expected EPS and the anticipation of positive guidance are key factors that could influence ACHV's stock price in the short term. However, the stock's past performance and the general bearish sentiment among long-term shareholders could temper any positive impact from the earnings report. The mixed historical reaction to past earnings reports suggests a cautious outlook.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100